The Amyloidosis market was $3.6 billion in 2017, and is expected to reach $6 billion in 2025, according to Grand View Research.
In other news, HPV vaccine is credited for lower death rate among women under 25; psilocybin is being tested to treat health care worker burnout; and more.
Traumatic brain injury (TBI) is a leading cause of death and disability among young people in the United States and is the most devastating survivable injury in modern warfare, according to the ...
Thermo Fisher's patent activity and acquisition strategy support growth. Find out why TMO stock is poised for continued ...
In a comprehensive Genomic Press Interview, distinguished psychiatrist Professor Peter Falkai suggests promising new ...
ShiraTronics has commenced the pivotal RELIEV-CM2 CLINICAL Study of its implantable neuromodulation therapy, designed for ...
Tribe Clinical Research in Greenville has announced the launch of a new trial for a drug centered around Alzheimer's ...
WW International, Inc. WW stock has shown a remarkable performance in the past three months, outpacing the S&P 500 and the ...
At Scripps Research, a research team led by Associate Professor Anne Hanneken, in the Department of Molecular Medicine, will ...
For people battling cancer, getting a chance to take part in a research trial of a new treatment can sometimes make a big difference. Starting next year, patients at the Avera Cancer Institute in ...